Document is current
Any future updates will be listed below
-
Authors
Michels-Zetsche, Julia D.
Röser, Evelyn
Ersöz, Hilal
Neetz, Benjamin
Dahlhoff, Jana C.
Joves, Biljana
Trinkmann, Frederik
Höger, Philipp
Kontogianni, Konstantina
Weissmann, Cornelia
Barre, Max
Fähndrich, Sebastian
Bornitz, Florian
Müller, Michael M.
Herth, Felix J. F.
Trudzinski, Franziska C.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 26 July 2024
Accepted: 19 September 2025
First Online: 8 October 2025
Declarations
:
: Julia D. Michels-Zetsche, Benjamin Neetz, Florian Bornitz, Michael M. Müller, Felix J.F. Herth and Franziska C. Trudzinski report a relationship with Federal Joint Committee of Doctors Hospitals and Health Insurers that includes: funding grants for the PRiVENT project. Outside the submitted work: FCT reports payment or honoraria for lectures, or reimbursement of travel expenses from Novartis AG, GlaxoSmithKline, Chiesi, Boehringer Ingelheim GmbH, Grifols, Streamed up, RG Gesellschaft für Information und Organisation mbH and AstraZeneca. JDMZ reports payment or honoraria for lectures from AstraZeneca and reimbursement of travel expenses from CSL Behring. FT reports personal fees from Actelion, Berlin Chemie, Boehringer Ingelheim, Chiesi, Novartis, Mundipharma, TEVA, Bristol-Myers Squibb, GlaxoSmithKline, Roche, AstraZeneca, Sanofi-Aventis. KK reports consulting fees from Cook Medical and honoraria from AstraZeneca, Berlin Chemie, Boston Scientific, Olympus medical. The other authors report no further competing interest concerning this manuscript.
: For the retrospective data analysis, a vote of the Ethics Committee of the Medical Faculty of the University of Heidelberg (No. S-666/2023) was obtained on 28.12.2023. The necessity for informed consent was waived by the Ethics Committee due to the retrospective nature of the study. This study was performed in accordance with the Declaration of Helsinki.
